Parabilis Medicines, Inc. (PBLS)

Parabilis Medicines will go public soon, but the exact IPO date is still unknown.

Stock Price: Pending

IPO price not available yet

Parabilis Medicines Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Selling, General & Admin	-	26.5	25.3
Research & Development	-	125.58	100.83
Operating Expenses	-	152.08	126.13
Operating Income	-159.29	-152.08	-126.13
Interest Expense (Income)	-3.14	-1.86	-4.92
Other Expense (Income)	-3.27	-4.33	-3.29
Pretax Income	-209.71	-186.93	-161.48
Net Income	-152.88	-145.89	-117.91
Preferred Dividends	56.83	41.04	43.57
Net Income Common	-209.71	-186.93	-161.48
Free Cash Flow	-139.36	-124.02	-104.49
EBITDA	-210.4	-186.3	-164.3
Depreciation & Amortization	2.45	2.5	2.11
EBIT	-212.85	-188.8	-166.4

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).